Is PYC up or down today?
PYC is up 1.29% today, last at 224.98. This stock moved +1.29% versus the prior close.
PYC · PYC
PYC (PYC) is trading at 224.98, up 1.29% on the session. Price signals are mixed — no clear one-way momentum read.
Leading the coverage: “PYC Therapeutics Ltd (ASX:PYC) in Focus: Why Investors Are Watching the Stock - Kalkine” (Google News Company, 10d ago). PYC is +3.48% since story.
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
PYC is up 1.29% today, last at 224.98. This stock moved +1.29% versus the prior close.
Leading the coverage: “PYC Therapeutics Ltd (ASX:PYC) in Focus: Why Investors Are Watching the Stock - Kalkine” (Google News Company, 10d ago). PYC is +3.48% since story. Dominant story: PYC Therapeutics Q3 2026 slides: late-stage transition accelerates By Investing.com - Investing.com Australia (2 sources, neutral) RSI unavailable Price sits at 50% of its 52-week range Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
PYC Therapeutics Q3 2026 slides: late-stage transition accelerates By Investing.com - Investing.com Australia
PYC: Multiple clinical milestones and clean safety data set stage for late-stage development and growth - TradingView
PYC Therapeutics Limited (PYCXF) Discusses Progress in Pipeline Programs and Upcoming Human Data Readouts - Slideshow (OTCMKTS:PYCXF) 2026-09-03 - Seeking Alpha
PYC: Multiple clinical readouts and a strong safety profile drive momentum toward late-stage trials - TradingView
PYC Therapeutics Q3 2026 slides: late-stage transition accelerates By Investing.com - Investing.com UK